Paul Sanberg Receives Everfront Award at Stem Cell Conference in Taiwan Dr. Paul Sanberg received the Everfront Award at the 4th Pan Pacific Symposium on Stem Cell and Cancer Research. [University of South Florida Press Release] OncoMed Pharmaceuticals and Bayer HealthCare Expand Cancer Stem Cell Collaboration with Clinical Manufacturing Agreement OncoMed Pharmaceuticals, Inc. announced it has expanded its collaboration with Bayer HealthCare. [OncoMed Pharmaceuticals, Inc. Press Release] UC Berkeley Launches Synthetic Biology Institute to Advance Research in Biological Engineering An alliance of top researchers at the University of California (UC), Berkeley, has formed the UC Berkeley Synthetic Biology Institute, advancing efforts to engineer cells and biological systems in ways that promise to transform technology in health and medicine, energy, the environment, new materials, and a host of other critical arenas. [University of California, Berkeley Press Release] USC Invests in Biomedical Engineering Innovations The University of Southern California (USC) Viterbi School of Engineering, the Keck School of Medicine of USC, the USC Stevens Institute for Innovation and the Los Angeles Basin Clinical Translational Science Institute have been selected to participate in the exclusive Coulter Translational Research Partnership Program. [University of Southern California Press Release] A. Alfred Taubman Increases His Support for Medical Science Institute at U-M to $100 Million A. Alfred Taubman has become University of Michigan (U-M)’s largest individual donor, with total giving of more than $142 million. [University of Michigan Health System Press Release] Whittier Foundation Awards $3 Million Nanotechnology Grant to Keck School The L.K. Whittier Foundation is awarding another $3 million to the nanobiotechnology initiative it established four years ago at the Keck School of Medicine. [University of Southern California Press Release] NIH Grant Launches Center for Reproductive and Stem Cell Biology The Center for Reproductive and Stem Cell Biology has been tapped to become one of a select group of National Institutes of Health (NIH) research centers, as a part of a grant of about $10 million awarded earlier. [Stanford University School of Medicine Press Release] NIH-Funded Centers to Assist Rehabilitation Researchers The National Institutes of Health (NIH) has provided approximately $30 million over a five year period to fund a network of centers to advance medical rehabilitation research. The centers provide researchers with access to new technologies and resources. [National Institutes of Health Press Release] RXi Pharmaceuticals Awarded $580,000 in NIH Grants to Advance RNAi Therapeutics RXi Pharmaceuticals Corporation announced that it was awarded two Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH). [RXi Pharmaceuticals Corporation Press Release] Rice Wins $1.2 Million for Heart-Valve Tissue Research A team of bioengineers from Rice University is bringing a promising new strategy for growing replacement heart valves closer to reality, thanks to a four-year, $1.2 million grant from the National Institutes of Health. [Rice University Press Release]
Celsense, Inc. Announces Patent Issued for New MRI Reporter Gene Celsense, Inc. announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application 11/080,732 with claims covering its MRI reporter gene product, Gene Sense. [Celsense, Inc. Press Release] International Stem Cell Successfully Completes First Series of Preclinical Testing of Hepatocytes Derived from Human Parthenogenetic Stem Cells International Stem Cell Corporation announces successful completion of the first series of preclinical testing of hepatocytes derived in the lab from human parthenogenetic stem cells. [International Stem Cell Corporation Press Release]
BCM Enrolling Patients for Parkinson’s Study Evaluating CERE-120 Restoring brain function and protecting brain cells of people suffering from Parkinson’s disease is the goal of a new double blind Phase IIb study evaluating CERE-120. Baylor College of Medicine (BCM) is one of 11 major U.S. medical centers currently enrolling patients. [Baylor College of Medicine Press Release] Tissue Genesis Begins FDA‐Approved Clinical Trial Tissue Genesis, Inc. announced that it has begun clinical trials for peripheral vascular disease with adipose derived adult stem cell‐coated vascular grafts at the University of Louisville Hospital. [Tissue Genesis, Inc. Press Release] Tarix Pharmaceuticals Enrolls First Patient in Phase I Clinical Study of TXA127 in Adult Patients Following Double Cord Blood Stem Cell Transplant Tarix Pharmaceuticals announced enrollment of the first patient in a Phase I clinical study of TXA127, a pharmaceutical grade formulation of a naturally occurring peptide known to stimulate early hematopoietic precursor cells in the bone marrow. [PR Newswire] OncoMed Pharmaceuticals Announces FDA Clearance to Commence Phase I Testing of Anti-Cancer Stem Cell Therapeutic OMP-18R5 OncoMed Pharmaceuticals, Inc. announced that the FDA has accepted an IND filing for OMP-18R5, which allows OncoMed to commence Phase I clinical testing. [OncoMed Pharmaceuticals, Inc. Press Release] Novelos Therapeutics Welcomes Five New Directors Novelos Therapeutics, Inc. announced that Dr. Rock Mackie, Mr. John Neis, Dr. John Niederhuber, Dr. Michael Tweedle and Dr. Jamey Weichert joined Novelos’ board of directors concurrently with the closing of the recently announced acquisition of Cellectar, Inc. [Novelos Therapeutics, Inc. Press Release] Arrowhead Research Announces RNAi Leader John J. Rossi, Ph.D. to Join Calando Scientific Advisory Board Arrowhead Research Corporation announced that John J. Rossi, Ph.D., a pioneer and one of the world leaders in the field of RNAi discovery and development, has joined majority owned subsidiary Calando Pharmaceuticals, Inc. as a senior advisor. [Arrowhead Research Corporation Press Release] Stanford Creates First PhD Program in Stem Cell Science Stanford University’s Faculty Senate approved the creation of what officials believe is the first stem cell science PhD program in the nation and, perhaps, the world. The new doctoral program in stem cell biology and regenerative medicine is also the first interdisciplinary doctoral program created by the School of Medicine in recent years. [Stanford University School of Medicine Press Release] |